Previous 10 | Next 10 |
R1 RCM Inc. provides services to increase medical provider reimbursements and is an industry that grows at 10.3% annually. Changing regulations and the need to scale medical care across America will position R1 RCM Inc. to attract larger healthcare providers to its products and servic...
MURRAY, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months...
MURRAY, Utah, April 07, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that Project Roadrunner Parent Inc., a wholly owned subsidiar...
Potential of telemedicine, big data, artificial intelligence, and administrative digitization in the healthcare sector is huge. EDOC has done quite an effective reshuffling of its portfolio. EDOC is on a downward trend, but has strong potential in the long run. For further d...
The following slide deck was published by R1 RCM Inc. in conjunction with this event. For further details see: R1 RCM (RCM) Presents At 42nd Annual Cowen Health Care Conference
MURRAY, Utah, March 01, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today released its 2021 Environmental, Social, and Governance (ESG) repor...
R1 RCM, Inc. (RCM) Q4 2021 Earnings Conference Call February 17, 2022, 8:00 am ET Company Participants Atif Rahim - Head, IR Joe Flanagan - President & CEO Rachel Wilson - EVP & CFO Conference Call Participants James Auh - Cowen Vikram Kesavabhotla - Baird Sean Dodge - RBC Capital Mar...
Gainers: Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen ISPC -10%. Poseida ...
R1 RCM press release (NASDAQ:RCM): Q4 GAAP EPS of $0.11 beats by $0.01. Revenue of $398.9M (+21.5% Y/Y) in-line. For further details see: R1 RCM GAAP EPS of $0.11 beats by $0.01, revenue of $398.9M in-line
MURRAY, Utah, Feb. 17, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2021...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...